Directory
>
Eleni Venetsanakos
Eleni Venetsanakos
VP, Translational Sciences | Day One Biopharmaceuticals
San Bruno, California, United States
Eleni Venetsanakos
Summary
Eleni Venetsanakos is a seasoned Vice President of Translational Sciences at Day One Biopharmaceuticals, with a rich background in oncology, drug development, and translational biology. She has a robust history of leading multi-disciplinary teams and driving innovative drug discovery programs, particularly in the realm of cancer therapeutics. Her expertise spans various domains including biomarker validation and in vivo pharmacology, showcasing her ability to bridge laboratory research with clinical applications. Eleni holds a PhD in Tumour Immunology and a Bachelor of Science with Honours in Biochemistry and Immunology from respected Australian universities. Throughout her career, she has contributed to significant advancements in the biopharmaceutical sector, particularly in the development of small molecule kinase inhibitors. Her collaborative approach and strategic vision have established her as a key player in the field. Eleni's work is characterized by a commitment to scientific excellence and a passion for improving patient outcomes through innovative therapies.
Eleni Venetsanakos
Work Experience
VP, Translational Sciences at
Day One Biopharmaceuticals
September 2021 - Present
Senior Director Translational Sciences at
Day One Biopharmaceuticals
October 2019 - September 2021
Director Pharmacology at
IDEAYA Biosciences
April 2017 - July 2019
Director Biology at
Principia Biopharma
March 2017 - April 2017
Associate Director Biology at
Principia Biopharma
January 2015 - March 2017
Lab Head at
Novartis
April 2006 - May 2014
Scientist II at
Chiron Corporation
September 2001 - April 2006
Postdoctoral Scientist at
Ucsf
September 1998 - August 2001
Eleni Venetsanakos
Education
University of Tasmania, Bachelor Of Science (Honours)
Flinders University, Phd
Frequently Asked Questions about Eleni Venetsanakos
What is Eleni Venetsanakos email address?
Eleni Venetsanakos's primary email address is ******************@novartis.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Eleni Venetsanakos work for?
Eleni Venetsanakos is a VP, Translational Sciences at Day One Biopharmaceuticals, a company specializing in Commercial physical research.
Where Eleni Venetsanakos graduated from?
Eleni Venetsanakos holds a degree in Biochemistry And Immunology from University of Tasmania.
How can I directly contact Eleni Venetsanakos?
To contact Eleni Venetsanakos directly, you can use the email address ******************@novartis.com. Complete contact information is available upon registration with Muraena.
Who is Eleni Venetsanakos?
Eleni Venetsanakos is a seasoned Vice President of Translational Sciences at Day One Biopharmaceuticals, with a rich background in oncology, drug development, and translational biology. She has a robust history of leading multi-disciplinary teams and driving innovative drug discovery programs, particularly in the realm of cancer therapeutics. Her expertise spans various domains including biomarker validation and in vivo pharmacology, showcasing her ability to bridge laboratory research with clinical applications. Eleni holds a PhD in Tumour Immunology and a Bachelor of Science with Honours in Biochemistry and Immunology from respected Australian universities. Throughout her career, she has contributed to significant advancements in the biopharmaceutical sector, particularly in the development of small molecule kinase inhibitors. Her collaborative approach and strategic vision have established her as a key player in the field. Eleni's work is characterized by a commitment to scientific excellence and a passion for improving patient outcomes through innovative therapies.
Eleni`s contact details
******************@novartis.com
******************@principiabio.com
******************@dayonebio.com
Colleagues
Vice President, Talent
Vice President of Sales
Vice President, Market Access and HEOR Strategy
VP, Associate General Counsel
Senior Vice President of Corporate Development
Vice President, CMC
Vice President, Development Operations
VP & Head of Clinical Pharmacology
Chief Medical Officer
Senior Vice President, Finance & Investor Relations